|
|||
|
Multiple Sclerosis Information
Favorite Links
This Month
Month Archive
|
Wednesday, July 15
by
All About MS
on Wed 15 Jul 2009 10:28 AM CST
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the launch of the innovative individually adjustable electronic injection device RebiSmart(TM) for the self-administration of Rebif(R) (interferon beta-1a), the company's disease-modifying more »
by
All About MS
on Wed 15 Jul 2009 12:00 AM CST
Patients with multiple sclerosis (MS) who adhere to their treatment with interferon (IFN) beta-1a without interruption have lower relapse and progression rates than patients who do not adhere to their medication as regularly more »
|
||